Advertisement for orthosearch.org.uk
Results 1 - 7 of 7
Results per page:
The Bone & Joint Journal
Vol. 104-B, Issue 6 | Pages 645 - 646
1 Jun 2022
Haddad FS


The Bone & Joint Journal
Vol. 103-B, Issue 7 | Pages 1325 - 1325
1 Jul 2021
Bentley G


The Bone & Joint Journal
Vol. 97-B, Issue 3 | Pages 391 - 397
1 Mar 2015
van Embden D Stollenwerck GANL Koster LA Kaptein BL Nelissen RGHH Schipper IB

The aim of this study was to quantify the stability of fracture-implant complex in fractures after fixation. A total of 15 patients with an undisplaced fracture of the femoral neck, treated with either a dynamic hip screw or three cannulated hip screws, and 16 patients with an AO31-A2 trochanteric fracture treated with a dynamic hip screw or a Gamma Nail, were included. Radiostereometric analysis was used at six weeks, four months and 12 months post-operatively to evaluate shortening and rotation.

Migration could be assessed in ten patients with a fracture of the femoral neck and seven with a trochanteric fracture. By four months post-operatively, a mean shortening of 5.4 mm (-0.04 to 16.1) had occurred in the fracture of the femoral neck group and 5.0 mm (-0.13 to 12.9) in the trochanteric fracture group. A wide range of rotation occurred in both types of fracture. Right-sided trochanteric fractures seem more rotationally stable than left-sided fractures.

This prospective study shows that migration at the fracture site occurs continuously during the first four post-operative months, after which stabilisation occurs. This information may allow the early recognition of patients at risk of failure of fixation.

Cite this article: Bone Joint J 2015;97-B:391–7.


The Bone & Joint Journal
Vol. 95-B, Issue 8 | Pages 1150 - 1150
1 Aug 2013
Ross A Birch R

We welcome letters to the Editor concerning articles that have recently been published. Such letters will be subject to the usual stages of selection and editing; where appropriate the authors of the original article will be offered the opportunity to reply.


The Journal of Bone & Joint Surgery British Volume
Vol. 92-B, Issue 9 | Pages 1186 - 1191
1 Sep 2010
Dineen PF Curtin RJ Harty JA

Antiplatelet agents are widely prescribed for the primary and secondary prevention of cardiovascular events. A common clinical problem facing orthopaedic and trauma surgeons is how to manage patients receiving these agents who require surgery, either electively or following trauma. The dilemma is to balance the risk of increased blood loss if the antiplatelet agents are continued peri-operatively against the risk of coronary artery/stent thrombosis and/or other vascular event if the drugs are stopped. The traditional approach of stopping these medications up to two weeks before surgery appears to pose significant danger to patients and may require review. This paper covers the important aspects regarding the two most commonly prescribed antiplatelet agents, aspirin and clopidogrel


The Journal of Bone & Joint Surgery British Volume
Vol. 88-B, Issue 3 | Pages 419 - 419
1 Mar 2006
Wade P


The Journal of Bone & Joint Surgery British Volume
Vol. 87-B, Issue 10 | Pages 1447 - 1447
1 Oct 2005
Shah RK